Psych Congress 2017

Switch to Aristada Significantly Improves Schizophrenia Symptoms

By September 19, 2017

The 6-month study examined the safety, efficacy, and tolerability of Aristada in patients with schizophrenia who had an inadequate response or intolerance to Invega Sustenna.

Evidence-Based Autism Treatment Models Continue to Grow

September 19, 2017

Recent changes in our understanding of autism are driving advances in diagnosis, evidence-based treatment, and ultimately patient outcomes.

Neuropsychopharmacological Approach to Disruptive Mood Dysregulation Disorder

September 18, 2017

Combination treatment may provide relief from the distinctive symptoms of severe, recurrent temper outbursts and persistent irritability.

Treatment Options for Obsessive Compulsive Disorder

September 18, 2017

Dr. Grant also acknowledged that while some patients are uncomfortable with the fact that medication doses for OCD are higher than they are for depression, those higher doses are crucial for symptomatic improvement.

Weighing the Benefits of Adjunctive Therapies in Major Depressive Disorder

September 18, 2017

Michael Thase, MD, discusses therapy options as well as side effect management for individuals with major depressive disorder.

Review Assesses Pharmacotherapy Efficacy in Alcohol, Substance Abuse

September 18, 2017

New pharmacotherapies in combination with psychotherapy and counseling have proven effective in preventing relapse. Re